SEARCH

SEARCH BY CITATION

References

  • 1
    Roberts JM, Lain KY. Obstetrics. Preterm birth and pre-eclampsia—bad news and good news. Lancet 1998;352(Suppl 4):SIV22.
  • 2
    Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small for gestational age infants. Br J Obstet Gynaecol 1986;93: 10491059.
  • 3
    Broughton Pipkin F. What is the place of genetics in the pathogenesis of preeclampsia?. Biol Neonate 1999;76: 325330.
  • 4
    Barden AE, Beilin LJ, Ritchie J, Walters BN, Michael C. Does a predisposition to the metabolic syndrome sensitize women to develop preeclampsia?. J Hypertens 1999;17: 13071315.
  • 5
    He S, Silveira A, Hamsten A, Blomback M, Bremme K. Haemostatic, endothelial and lipoprotein parameters in women with a history of preeclampsia. Thromb Haemost 1999;81: 538542.
  • 6
    Hubel CA, Snaedal S, Ness RB, et al. Dyslipoproteinemia in postmenopausal women with a history of preeclampsia. Br J Obstet Gynaecol 2000;107: 776784.
  • 7
    Hubel CA, Roberts JM, Ferrell RE. Association of preeclampsia with common coding sequence variations in the lipoprotein lipase gene. Clin Genet 1999;56: 289296.
  • 8
    Lundman P, Eriksson M, Schenck-Gustafsson K, Karpe F, Tornvall P. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation 1997;96: 32663268.
  • 9
    Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998;141: 115.
  • 10
    Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6: 6775.
  • 11
    Lunec J. Free radical activity; methods of measurement in vivo. Pharmacological Methods in the Control of Inflammation. In: ChangJY, LewisAJ editors. Modern Methods in Pharmacology New York : Alan R. Liss, 1989: 5: 5991
  • 12
    Anderson TJ, Meredith IT, Charbonneau F, et al. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation 1996;93: 16471650.
  • 13
    Zuspan FP. The hypertensive disorders of pregnancy: report of a WHO study group. Technical Report Series 758. Geneva: WHO, 1987.
  • 14
    Gratacós E, Casals E, Deulofeu R, Cararach V, Alonso PL, Fortuny A. Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy. Am J Obstet Gynecol 1998;178(5):10721076.
  • 15
    Griffin BA. Lipoprotein atherogenicity: an overview of current mechanisms. Proc Nutr Soc 1999;58: 163169.
  • 16
    Chait A, Brazg RL, Tribble DL, Krauss RM. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993;94: 350356.
  • 17
    Vogel RA. Cholesterol lowering and endothelial function. Am J Med 1999;107: 479487.
  • 18
    Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism 1998;47: 12811288.
  • 19
    Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997;89: 403408.
  • 20
    Wakatsuki A, Ikenoue N, Okatani Y, Shinohara K, Fukaya T. Lipoprotein particles in preeclampsia: susceptibility to oxidative modification. Obstet Gynecol 2000;96: 5559.
  • 21
    Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of preeclampsia?. Lancet 1999;354: 788789.
  • 22
    Gratacós E. Lipid mediated endothelial dysfunction as a common factor to preeclampsia and chronic vascular disease. Eur J Obstet Gynecol 2000;92: 6366.
  • 23
    Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990;82: 495506.
  • 24
    De Wolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am J Obstet Gynecol 1975;123: 164174.
  • 25
    Broughton Pipkin F. Risk factors for preeclampsia. N Engl J Med 2001;344: 925926.